title: Immunogenicity of Brucella abortus salt-extractable proteins.
abstract: The immunogenic properties of salt-extractable proteins and chromatographic fractions thereof from Brucella abortus were evaluated in lemmings (Dicrostonyx rubricatus). The efficacy of the Brucella proteins as immunogens was determined after challenge with virulent B. abortus strain 2308 and was based on protection against clinical signs and gross lesions of brucellosis, as well as on numbers of viable Brucella in the spleen. Vaccination of lemmings with as little as 0.1 microgram of salt-extractable proteins (CSP) suppressed splenic infection, resulting in reduced numbers of viable organisms per spleen of 5-6 logs compared to non-vaccinated controls. Protein fractions separated by column chromatography were generally effective in reducing splenic infection, and contained proteins with molecular weights of 30,000, 20,000 and 12,000. Vaccines containing chemically modified dodecanoyl-CSP offered no additional advantage over unmodified CSP vaccines.
authors.affiliation: National Animal Disease Center, U.S. Department of Agriculture, Ames, IA 50010.
authors.forename: L B
authors.initials: LB
authors.lastname: Tabatabai
authors.forename: B L
authors.initials: BL
authors.lastname: Deyoe
authors.forename: J M
authors.initials: JM
authors.lastname: Patterson
mesh_terms: D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D003411:Arvicolinae; D001426:Bacterial Proteins / Q000276:immunology*; D001428:Bacterial Vaccines / Q000276:immunology*; D002003:Brucella abortus / Q000276:immunology*; D002006:Brucellosis / Q000517:prevention & control / Q000662:veterinary*; D013158:Splenic Diseases / Q000517:prevention & control / Q000662:veterinary
chemical_list: D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D001428:Bacterial Vaccines